共 50 条
- [1] Efficacy and safety of apremilast for the treatment of Japanese patients with palmoplantar pustulosis: Results from a phase 2, randomized, placebo-controlled study[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50Terui, TadashiOkubo, YukariKobayashi, Satomi
- [2] Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study[J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 837 - 847Terui, TadashiOkubo, YukariKobayashi, SatomiSano, ShigetoshiMorita, AkimichiImafuku, ShinichiTada, YayoiAbe, MasatoshiYaguchi, MasafumiUehara, NatsukaHanda, TakahiroTanaka, MasayukiZhang, WendyParis, MariaMurakami, Masamoto
- [3] Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study[J]. American Journal of Clinical Dermatology, 2024, 25 : 165 - 167Tadashi TeruiYukari OkuboSatomi KobayashiShigetoshi SanoAkimichi MoritaShinichi ImafukuYayoi TadaMasatoshi AbeMasafumi YaguchiNatsuka UeharaTakahiro HandaMasayuki TanakaWendy ZhangMaria ParisMasamoto Murakami
- [4] Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study (vol 24, pg 837, 2023)[J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (01) : 165 - 167Terui, TadashiOkubo, YukariKobayashi, SatomiSano, ShigetoshiMorita, AkimichiImafuku, ShinichiTada, YayoiAbe, MasatoshiYaguchi, MasafumiUehara, NatsukaHanda, TakahiroTanaka, MasayukiZhang, WendyParis, MariaMurakami, Masamoto
- [5] Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study[J]. DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1863 - 1873Okubo, YukariTerui, TadashiKobayashi, SatomiSano, ShigetoshiMorita, AkimichiImafuku, ShinichiTada, YayoiAbe, MasatoshiYaguchi, MasafumiKimura, TakeshiShimauchi, JunichiroZhang, WendyAmouzadeh, HamidMurakami, Masamoto
- [6] CYCLOSPORINE IN THE TREATMENT OF PALMOPLANTAR PUSTULOSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY[J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (10) : 1273 - 1279REITAMO, SERKKO, PREMITZ, ALAUERMA, AIMONTONEN, OHARJULA, K
- [7] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis[J]. DERMATOLOGY AND THERAPY, 2021, 11 (06) : 2179 - 2193Bissonnette, RobertMaari, CatherineTsianakas, AthanasiosReid, DeAnneMcCutchan, SaraBaumgartner, ScottMackay, JamesBhakta, Nihar
- [8] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis[J]. Dermatology and Therapy, 2021, 11 : 2179 - 2193Robert BissonnetteCatherine MaariAthanasios TsianakasDeAnne ReidSara McCutchanScott BaumgartnerJames MackayNihar Bhakta
- [9] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410Bissonnette, R.Haydey, R.Rosoph, L. A.Lynde, C. W.Bukhalo, M.Fowler, J. F.Delorme, I.Gagne-Henley, A.Gooderham, M.Poulin, Y.Barber, K.Jenkin, P.Landells, I.Pariser, D. M.
- [10] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study[J]. HEADACHE, 2021, 61 (06): : 927 - 935Takeshima, TakaoSakai, FumihikoHirata, KoichiImai, NoboruMatsumori, YasuhikoYoshida, RyujiPeng, ChengCheng, SunfaMikol, Daniel D.